期刊文献+

祛疣洗剂预防尖锐湿疣术后复发的临床研究 被引量:3

Clinical research of prevention effect on anti-wart lotion treating the recrudescent condylomata acuminate after surgery
下载PDF
导出
摘要 目的:探讨祛疣洗剂对尖锐湿疣(CA)术后复发的预防作用和安全性。方法:采用随机配对的临床研究方法;治疗组67例,运用激光配合祛疣洗剂联合治疗,对照组67例,单纯激光治疗;使用统一的评定标准进行疗效评价和安全性考察。结果:治疗组治愈率和复发率分别为88.06%和11.94%,对照组治愈率和复发率分别为55.22%和44.78%;两组比较,治愈率和复发率均有极显著性差异(P<0.01)。结论:激光配合祛疣洗剂治疗CA可增加其治愈率,减少复发率,证实祛疣洗剂对CA术后的复发有良好的预防作用。 Objective:To research the prevention effect and safety of Anti-wart lotion treating CA recrudescence after surgery. Methods: Random partnership clinical research method is used. In the treating group, 67 patients are treated by razor combinated with Anti-wart lotion. In the comparing group, 67 patients are treated by razor. The curative effect and the safety are determined by the standard of PASI. Results: The ratios of efficiency of the two groups are 88.06% and 55.22% respectively, and the ratios of recrudescence are 11.94% and 44.78% respectively. The ratios of efficiency and recrudescence of the two groups have obviously difference (P 〈 0. 01 ). Conclusions: Razor combined with anti-wart lotion treating CA can increase the ratio of efficiency and reduce the ratio of recrudescence. It's proved that Anti-wart lotion has good prevention on the recrudescence of CA after surgery.
出处 《药学与临床研究》 2009年第1期51-53,共3页 Pharmaceutical and Clinical Research
基金 南通市指令性社会发展科技计划项目(编号:S7911)
关键词 尖锐湿疣 激光 祛疣洗剂 临床疗效 安全性 Condylomata acuminate Razor anti-wart lotion Clinical curial effect Safety
  • 相关文献

参考文献6

二级参考文献19

  • 1顾恒,曾凡钦,郭在培,彭振辉,毕志刚,朱学骏,陈昆,郭庆,张谊之,闫乎铃,张美华,韩钢文,常宝珠,刘训荃(指导),王家璧(指导).咪喹莫特乳膏治疗尖锐湿疣随机、双盲、多中心研究[J].中华皮肤科杂志,2003,36(9):501-504. 被引量:96
  • 2陶苏江,顾军,赵广,李明.5%咪喹莫特乳膏治疗尖锐湿疣的临床研究[J].中国皮肤性病学杂志,2006,20(3):147-148. 被引量:22
  • 3Tsukui T,Allan H. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptide: correlation with cervical pathology[J ]. Cancer Res, 1996,56: 3967 - 3974.
  • 4Caude R, Tyring SK, Grossi CE, et al. Patients with condyloma acuminature exhibit decreased intrleukin-2 and interferine gamma production and depressed natural killer activity [ J ]. J Clin Immunol, 1987,7 (4) :304.
  • 5Nicholas C,Humphorey DL. Immunological events in regressing genital warts[J]. Am J Clin Pathol, 1994,768 - 774.
  • 6Roaquet N, Allemand I, Molina T, et al. Fas-dependent apoptosisis impaired by SV40 T-antigen in transgenic liver[J]. Oncogene, 1995, 11(6) :1061 - 1067.
  • 7Berthou C, Michel L, Soulie A, et al. Acquisition of granzyme B and Fas ligand proteins by human keratinocytes contributes to epidermal cell defense[J]. J Immunol, 1997,159 : 5293-5300.
  • 8Wilekes GK, Kulms D, Luger TA, et al. IL-1 protects keratinocytes from TRAIL and CD95-induced apoptosis but not from UV radiation induced apoptosiss[ J ]. J Boil Chem, 1999,274 (4) : 28916.
  • 9Ashkenazi A, Pai RC, Fong S, et al. Safety and antitumor activity of recombinant soluble APO2 ligand[J].J Clin Invest,1999,104(2):155.
  • 10Schiller J,Lowy DR.Papillomavirus-like particles and HPV vaccine development[J].Semin cancer Biol,1996,7(4):373.

共引文献67

同被引文献9

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部